Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Scientific evidence for the control of antimicrobial resistance

Bibliographic Data

ID14966728
AuthorsCelia Mercedes Alpuche Aranda (National Public Health Institute, Mexico City, Mexico), C Aranda (corresponding author), Cesar A Arias (0000-0001-9054-9774, The University of Texas Health Science Center at Houston, Houston, United States of America and Universidad El Bosque, Bogotá, Colombia), CARLOS TEJADA (0000-0001-8121-8658, Florida International University), Carlos Espinal Tejada (Florida International University), Corey Forde (Queen Elizabeth Hospital, Bridgetown, Barbados), Benjamin Park (0000-0001-7119-5632, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, United States of America), Flávia Rossi (0000-0002-8168-2319, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Monica Thormann (Pan American Association of Infectious Diseases, Santo Domingo, Dominican Republic)
Year2020
Volume44
Pages1
Publication date2020-12-17
Open AccessYes
TypeARTICLE
VenueRevista Panamericana de Salud Pública (JOURNAL)
Journal identifiersISSN: 1020-4989 • E-ISSN: 1680-5348
PublisherPan American Health Organization (PUBLISHER • US)
DOI10.26633/rpsp.2020.128
PMID33346236
OpenAlexW3112825336
LanguageEN
References cited3

[Extract]. Antimicrobial resistance (AMR) is one of the greatest global threats to human health. It is estimated that by 2050, AMR will lead to approximately 10 million annual deaths worldwide. Considering the impact of AMR on reproductive capacity and food production, in addition to its direct effect on infected people, the world's population could drop by between 11 and 444 million inhabitants by 2050 if AMR control is not achieved. As migrations and shared economies lead to the transmission of resistant bacteria across borders, the impacts of AMR become regionally significant. In the United States, methicillin-resistant Staphylococcus aureus caused 10 600 deaths in 2017. In Latin American and Caribbean countries, information is available from studies conducted in hospitals and other health facilities on the prevalence of antimicrobial-resistant pathogens. In many hospitals in Mexico, Peru, and Colombia, for example, resistance to third-generation cephalosporins and fluoroquinolones in Escherichia coli isolates is reaching almost 60%. Moreover, the dynamics of colonization and infection of multidrug-resistant organisms (such as carbapenemaseproducing Klebsiella pneumoniae) are unique in endemic areas of Latin America, favoring spread and dissemination. [...]

Antibiotic resistance · Antibiotics · Antimicrobial · Biology · Drug resistance · Environmental health · Escherichia coli · Geography · Klebsiella pneumoniae · Latin Americans · Multiple drug resistance · Political science · Population · Transmission (telecommunications · Antibiotic Resistance in Bacteria · Antibiotic Use and Resistance · Medicine · Pharmaceutical and Antibiotic Environmental Impacts · Microbiology

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae